The big-picture story out there continues to be the battle between bad news (rising infections, high unemployment, too many crumbling businesses) and good news (progress toward vaccines, therapeutics, etc.; accommodative policies from the Fed; improving fundamentals for some businesses arising from the pandemic). there’s...
Read More
Micro Caps Continue to be Ignored
This week, we profile Greystone Logistics (GLGI), a classic micro-cap company that is growing earnings 140% this year but only trades at 6.6x earnings.
Why is the company so cheap? Because it’s a micro cap!
If this company had a cap...
Read More
The Big Idea
If there was ever any doubt that digital payments is a big trend the coronavirus pandemic has squashed the argument.
Locked up at home, people have still needed to buy things and pay their bills. Businesses, from car and boat dealerships to to...
Read More
The big news affecting the market this week is the upward trend in coronavirus cases in some states and the resulting concern that an economic rebound will be curbed sooner than hoped.
Read More
The market continues to recover from last week’s short but intense decline. In our portfolio there’s been a dearth of news flow. That’s fine with me. I think we could all use a little less stimulation and step back from our computers and devices...
Read More
We’re finally starting to see signs that investors are realizing that risk actually does exist in the market (I think).
Read More
Patience Will Pay Off
This week, we profile Liberated Syndication (LSYN), an under-the-radar podcast hosting company in secular growth that is about to announce the results of a strategic review. Make sure to use limits when buying LSYN as the stock is very illiquid.
Our recommendations...
Read More
The Big Idea
We’ve enjoyed tremendous success investing early in off-the-beaten path insurance brokerage companies.
This success is due, in large part, to selecting technology-enabled companies with business plans developed around efficiently capturing, and keeping, clients.
These companies include Goosehead Insurance (GSHD) and Everquote (EVER). Both rapid-growth,...
Read More
In the market, there seems to be some rotation going on. Or at least that was my sense of things over the first two and a half trading days of the week.
Read More
We’ve been waiting for a pullback in high growth names and that looks to have begun this week.
Read More
Enjoy the current strength but be aware of the environment we’re in, and why. Accept that we could see a significant retreat in the prices of many of our stocks in the near term, but that the fundamental reasons behind their current strength persist...
Read More
Under normal market conditions growth investors like to get pulled into strong stocks and buy them as they head higher. This is anything but a normal market, however!
Read More
This health-care data stock reported after the close yesterday with results that beat lowered expectations.
Read More
Welcome to Cabot Micro-Cap Insider
Welcome to Cabot Micro-Cap Insider!
If you have not already, I recommend that you read my Cabot Micro-Cap Insider Guide. It will help you get the most out of your Cabot Micro-Cap Insider membership, and make your investing decisions easier more...
Read More
This portfolio stock reported earnings and moves to Buy.
Read More
Two portfolio stocks reported earnings today.
Read More
Three portfolio stocks reported earnings today, and we're selling one for a nice profit.
Read More
The Big Idea
While the world is laser-focused on potential treatments and vaccines for COVID-19 there are still other other life-threatening diseases for which we need better treatments.
Take, for example, multiple myeloma, the second-most common blood cancer in the U.S. The market for treatment is...
Read More
Three portfolio stocks reported earnings today, and one moves to Hold.
Read More
This portfolio stock has exploded over 25% to all-time highs following a beat and raise Q1 that seemed in the cards, but still comes very much as a surprise to me.
Read More